Theriva Biologics Inc.
Organization details
- Legal name
- Theriva Biologics Inc.
- Former names
- Synthetic Biologics, Inc. Adeona Pharmaceuticals, INC. Pipex Pharmaceuticals, INC. Sheffield Pharmaceuticals Inc Sheffield Medical Technologies Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Rockville
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- TOVX
- Primary stock exchange
- NYSE American
Identifiers
- SEC CIK
- 0000894158
- EIN
- 13-3808303
Board of directors
-
Jeffrey Alan Wolf · DirectorSince 2023
-
Jeffrey J. Kraws · DirectorSince 2023
-
John J. Monahan · DirectorSince 2023
-
Steven A. Shallcross · Director · CEO and CFOSince 2023
Chief executives
Director election results
Annual meeting of August 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.1%
-
66.6%
-
66.6%
-
66.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 7, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +14,000 | $0.69 | $9,660 |
| Jun 6, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +26,000 | $0.63 | $16,380 |
| Feb 10, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $1.04 | $26,000 |
| Feb 2, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.94 | $23,500 |
| Jan 25, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.87 | $21,750 |
| Jan 20, 2023 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +25,000 | $0.75 | $18,750 |
| Dec 29, 2022 | Steven A. Shallcross Director, Officer (CEO and CFO) | Open-market purchase | +100,000 | $0.44 | $44,000 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Theriva Biologics Inc.
Who is the CEO of Theriva Biologics Inc.?
Steven A. Shallcross is Theriva Biologics Inc.'s CEO and CFO.
How many directors are on Theriva Biologics Inc.'s board?
Theriva Biologics Inc.'s board has 4 directors: Jeffrey Alan Wolf, Jeffrey J. Kraws, John J. Monahan and Steven A. Shallcross.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="theriva-biologics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.